FDA Approved: * August 9, 2021 Pharm Company: *CIPLA Category:Vision / Eye Health
Difluprednate is a corticosteroid, It is chemically a butyrate ester of 6(alpha),9(alpha)-difluoro prednisolone acetate. Accordingly, difluprednate is sometimes abbreviated DFBA, for difluoroprednisolone butyrate acetate.
Approval
On June 24, 2008, the US Food and Drug Administration (FDA) approved difluprednate for the treatment of post-operative ocular inflammation and pain.[1] It is marketed by Alcon under the tradename Durezol.
Clinical trials
Difluprednate ophthalmi...
[wikipedia]
* May have multiple approval dates, manufacturers, or labelers.